Volpara Health Technologies Limited

February 25, 2020 - 1 month ago
Share on twitter
Share on facebook
Share on linkedin
Share on email

Technical outlook – At present, the weekly timeframe displays a bearish Moving Average Convergence Divergence (MACD), mainly supported to the recent rejection from the area of $2.00-20 back in late November 2019.

Also note, that the Relative Strength Index (RSI) 3-week-lookback in heading into oversold territory, to which, also supports the rebound soon.

Therefore, we view Volpara Health Technologies Limited (VHT) may have further ground to cover to the downside, (in the short-term), until the challenge is expected to emerge from the 3-year trend support (broader/primary trend) at $1.28-30, before the likelihood of any profit-taking emerging.

Company Overview – Volpara Health Technologies Limited (VHT) develops digital health solutions to enable personalised, high-quality breast cancer screening based on objective measurements of breast density, compression and radiation dose.

Share on twitter
Share on facebook
Share on linkedin
Share on email

Leave a Reply

Close Menu